New drug duo trial targets prostate Cancer's genetic weakness
NCT ID NCT03012321
Summary
This study is testing whether combining two existing drugs works better than using them alone for men with advanced prostate cancer that has specific genetic flaws. It is for men whose cancer has spread and is no longer responding to standard hormone-blocking treatments. The trial will compare the effectiveness and safety of the drug combination against each drug by itself.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATE CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope National Medical Center
Duarte, California, 91010, United States
-
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, 33612, United States
-
Huntsman Cancer Institute - University of Utah
Salt Lake City, Utah, 84112, United States
-
Indiana University/ Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, 46202, United States
-
Karmanos Cancer Center
Detroit, Michigan, 48201, United States
-
Kellogg Cancer Center - NorthShore University
Evanston, Illinois, 60201, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Northwestern Medicine
Chicago, Illinois, 60611, United States
-
Rush University Cancer Center
Chicago, Illinois, 60612, United States
-
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, 08903, United States
-
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, 21231, United States
-
University of California Los Angeles
Los Angeles, California, 90073, United States
-
University of Chicago
Chicago, Illinois, 60637, United States
-
University of Michigan Health System
Ann Arbor, Michigan, 48109-5946, United States
-
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27514, United States
-
University of Virginia
Charlottesville, Virginia, 22903, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
-
Weill Cornell Medical College
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.